Partners and Collaborators

SDG's business model includes the creation of technology-focused companies that operate from licenses to SDG technology applications. AMDG, Inc., Diasome Pharmaceuticals, Inc. (, and Targeted Nano Therapeutics ( are representative of new companies that SDG has been instrumental in forming and managing. SDG is also pleased to be an Equity Partner Company of the Cleveland Clinic Foundation ( and a resident company in the Clinic's new Global Cardiovascular Innovation Center.



SDG's delivery technologies are available for in-licensing. For more information, Please email us at